Company intelligence / Profile preview

SATT Nord

Lille, Hauts-de-France, Francesattnord.fr ↗

Ownership: Private
Development stage: Other

Overview

SATT Nord accelerates the maturation and commercialization of academic research innovations in Northern France. It identifies promising projects, protects intellectual property, invests in development and licenses or spins out new companies. It has enabled numerous startups and licensing deals across sectors including life sciences.

Industry: Investors

Partnerships

Apmonia Therapeutics (licensing agreement)Regional universities and public research organizations in Hauts-de-France and Champagne-Ardenne

Beyond the preview

Go deeper on SATT Nord.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SATT Nord.

Explore the full profile